Safety of Extracellular Vesicles for Burn Wounds

Phase 1 Completed 1 enrolled Aegle Therapeutics Congressionally Directed Medical Research Programs · collab

NaSingle-groupOpen-labelTreatment

Summary

Treatment of patients with deep second degree burns of the skin with extracellular vesicles (EV) isolated from bone marrow derived mesenchymal stem cells.

Timeline

Start: 2023-08-10
Primary completion: 2024-09-05
Completion: 2024-11-19

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AGLE-102	Other / unclassified	1e+07 unknown	—

Indications

No indication recorded.